S100a8 and s100a9 are elevated in aortic wall from patients with moderate-and-severe obstructive sleep apnea syndrome
Sleep and Breathing · 2025
DOI: 10.1007/s11325-025-03400-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sleep and Breathing, 2025. Verfasst von Ewa Migacz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Calgranulin B, Calgranulin A, Aorta. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
PURPOSE: Obstructive sleep apnea (OSA) is associated with systemic inflammation and cardiovascular disease, including atherosclerosis. S100A8 and S100A9 are pro-inflammatory proteins involved in atherogenesis, but their expression in the aortic walls of OSA patients remains unknown. This study aimed to determine the relationship between OSA severity and S100A8/S100A9 expression in aortic tissue from patients undergoing coronary artery bypass grafting (CABG). METHODS: This study included 46 patients who underwent CABG. OSA severity was assessed using the WatchPAT™ home sleep apnea test, classifying patients into control and mild (0 < AHI < 15), and moderate to severe (AHI ≥ 15) OSA groups. Aortic wall samples were collected intraoperatively, and S100A8 and S100A9 expression was evaluated using immunohistochemistry. Statistical analysis compared protein expression across OSA severity groups. RESULTS: Patients with moderate-to-severe OSA exhibited higher S100A8 and S100A9 expression in aortic tissue compared to control and mild OSA groups. The difference was statistically significant for S100A9 (p < 0.01), while S100A8 showed a non-significant increasing trend (p = 0.073). CONCLUSION: This study provides novel evidence that S100A8 and S100A9 are overexpressed in the aortic walls of patients with moderate-to-severe OSA. These findings suggest a potential role for these proteins in OSA-related vascular inflammation and atherosclerosis. Further research is needed to explore their potential as biomarkers or therapeutic targets in OSA-related cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Faculty of Medicine and Dentistry, Medical University of Warsaw, Warsaw, Poland.
- Department of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Poland.
- Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
- Department of Cardiac and Vascular Surgery, Medical University of Gdansk, Gdansk, Poland.
- Department of Clinical Pathology, Poznan University of Medical Sciences, Poznan, Poland.
- Divisions of Pediatric Otolaryngology and Pulmonary and Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, USA.
ORCID-Profile: Wojciech Kukwa
Zitieren
APA
Migacz, E., Olejarz, W., Łoś, A., Bednarek-Rajewska, K., Smith, D. F., Kluk, A., & Kukwa, W. (2025). S100a8 and s100a9 are elevated in aortic wall from patients with moderate-and-severe obstructive sleep apnea syndrome. Sleep and Breathing. https://doi.org/10.1007/s11325-025-03400-5
Vancouver
Migacz E, Olejarz W, Łoś A, Bednarek-Rajewska K, Smith DF, Kluk A, et al. S100a8 and s100a9 are elevated in aortic wall from patients with moderate-and-severe obstructive sleep apnea syndrome. Sleep and Breathing. 2025. doi:10.1007/s11325-025-03400-5
BibTeX
@article{Migacz2025,
author = {Migacz, Ewa and Olejarz, Wioletta and Łoś, Andrzej and Bednarek-Rajewska, Katarzyna and Smith, David F and Kluk, Andrzej and Kukwa, Wojciech},
title = {S100a8 and s100a9 are elevated in aortic wall from patients with moderate-and-severe obstructive sleep apnea syndrome},
journal = {Sleep and Breathing},
year = {2025},
doi = {10.1007/s11325-025-03400-5}
}
EUVIMED